🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Important time for patients suffering the threat of limb loss. Looking forward to the exciting work we have ahead of us in helping to evaluate this technology for our patients. Ramon Varcoe Sahil A. Parikh, MD

Abbott Begins LIFE-BTK Trial to Evaluate Esprit BTK Drug-Eluting Resorbable Scaffold to Treat CLI | Abbott evtoday.com/news/abbott-be…

The first patient has been successfully treated with our Esprit BTK Everolimus Eluting Resorbable Scaffold System, pioneering a new standard of care in BTK treatment. Thanks Dr. Prakash Krishnan and team for your commitment to your patients. Safety Info: bit.ly/3WAocNk

Spending the morning with Brian DeRubertis, MD, FACS observing the first commercial Esprit BTK case at Cornell is a great way to start the day. We are excited about what this therapy is bringing to patients. Abbott Cardiovascular #ProudtobeAbbott

We followed a great morning with a wonderful afternoon watching the first Esprit BTK commercial case at Columbia performed by Sahil A. Parikh, MD Abbott Cardiovascular #ProudtobeAbbott

Register now: viva-foundation.org/register

#VIVA24: Along with Lorenzo Patrone who is still in transit to Las Vegas, Jordan R. Stern, MD receives the 2024 VCA Award from The VIVA Foundation. The accolade is given to young physician-leaders for vascular career advancement.